Electra Therapeutics, Inc. (ETRA) research

Electra Therapeutics, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$10.37
As of

Electra Therapeutics, Inc. (ETRA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-21.

As of . Source: SEC EDGAR filings for ETRA. Method and limitations.

SHARE THIS CARD

Share the ETRA intelligence card

A branded snapshot of ETRA: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion ETRA intelligence card preview
Post to X
COMPANY DOSSIER

See the full ETRA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ETRA on one page. Preview it with sample data, then open it live with a free account.

Preview the ETRA dossier

Active signals for ETRA

No recent signals on ETRA in the last 180 days.

FREE, NO ACCOUNT

Every signal on ETRA, as it fires

New filings, 13F moves and cross asset signals on ETRA land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, ETRA

Related tickers

See more ETRA signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ETRAand get the insider, 13F, options, and confluence read in one view.

Preview the ETRA dossier